Steward Partners Investment Advisory’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.29K Buy
401
+1
+0.3% +$4 ﹤0.01% 4211
2026
Q1
$1.55K Sell
400
-200
-33% -$821 ﹤0.01% 4115
2025
Q4
$2.51K Hold
600
﹤0.01% 3897
2025
Q3
$1.97K Hold
600
﹤0.01% 3928
2025
Q2
$852 Hold
600
﹤0.01% 3894
2025
Q1
$894 Sell
600
-1
-0.2% -$2 ﹤0.01% 3791
2024
Q4
$673 Sell
601
-2,699
-82% -$2.3K ﹤0.01% 3813
2024
Q3
$3.13K Hold
3,300
﹤0.01% 3323
2024
Q2
$5.21K Sell
3,300
-100
-3% -$145 ﹤0.01% 3026
2024
Q1
$4.93K Hold
3,400
﹤0.01% 3048
2023
Q4
$4.56K Hold
3,400
﹤0.01% 2993
2023
Q3
$4.83K Hold
3,400
﹤0.01% 2841
2023
Q2
$3.91K Sell
3,400
-132
-4% -$156 ﹤0.01% 2872
2023
Q1
$3.74K Hold
3,532
﹤0.01% 2877
2022
Q4
$5.37K Sell
3,532
-690
-16% -$1.19K ﹤0.01% 2753
2022
Q3
$9K Hold
4,222
﹤0.01% 2582
2022
Q2
$6K Sell
4,222
-700
-14% -$1.04K ﹤0.01% 2705
2022
Q1
$10K Hold
4,922
﹤0.01% 2670
2021
Q4
$18K Sell
4,922
-900
-15% -$3.87K ﹤0.01% 2370
2021
Q3
$29K Sell
5,822
-900
-13% -$5.18K ﹤0.01% 2158
2021
Q2
$44K Hold
6,722
﹤0.01% 3623
2021
Q1
$46.3K Sell
6,722
-500
-7% -$4.23K ﹤0.01% 2026
2020
Q4
$74K Buy
7,222
+1,300
+22% +$8.43K ﹤0.01% 1489
2020
Q3
$21K Hold
5,922
﹤0.01% 1884
2020
Q2
$30K Hold
5,922
﹤0.01% 1614
2020
Q1
$20K Sell
5,922
-900
-13% -$3.88K ﹤0.01% 1615
2019
Q4
$37K Sell
6,822
-934
-12% -$5.26K ﹤0.01% 1530
2019
Q3
$44K Buy
7,756
+100
+1% +$679 ﹤0.01% 1411
2019
Q2
$58K Buy
+7,656
New +$41.2K ﹤0.01% 1284
2018
Q4
Sell
-11,306
Closed -$195K 1746
2018
Q3
$195K Sell
11,306
-445
-4% -$6.62K 0.01% 728
2018
Q2
$164K Sell
11,751
-900
-7% -$15.2K 0.01% 708
2018
Q1
$193K Buy
12,651
+3,700
+41% +$52.9K 0.01% 625
2017
Q4
$103K Buy
8,951
+2,575
+40% +$38.4K 0.01% 632
2017
Q3
$121K Hold
6,376
0.01% 511
2017
Q2
$153K Sell
6,376
-80
-1% -$1.75K 0.02% 444
2017
Q1
$127K Buy
+6,456
New +$144K 0.02% 393

Other funds holding PGEN

Steward Partners Investment Advisory's PGEN Position: Q2 2026 in Review

Steward Partners Investment Advisory increased its Precigen (PGEN) stake by 0.25% in Q2 2026, buying an estimated $4 and bringing the position to 401 shares worth $2.29K. The position accounts for ﹤0.01% of the portfolio, ranked #4211.

Steward Partners Investment Advisory first reported a position in PGEN in Q1 2017 and has held it in 36 quarters since. The position peaked at $195K in Q3 2018. 211 funds tracked by Wall St. Rank hold PGEN as of Q2 2026.

  • Steward Partners Investment Advisory held 401 shares of Precigen worth $2.29K as of Q2 2026.
  • Steward Partners Investment Advisory bought 1 Precigen share in Q2 2026, an estimated $4.
  • Precigen made up ﹤0.01% of Steward Partners Investment Advisory's portfolio in Q2 2026, its #4211 holding.
  • Steward Partners Investment Advisory first reported a position in Precigen in Q1 2017 and has held it in 36 quarters since.
  • Steward Partners Investment Advisory's Precigen position peaked at $195K in Q3 2018.
  • 211 funds tracked by Wall St. Rank held Precigen as of Q2 2026.

Based on Steward Partners Investment Advisory's 13F filing for Q2 2026, filed 13 Aug 2026.